Correction to Lancet Respir Med 2020; published online Feb 21. https://doi.org/10.1016/S2213-2600(20)30079-5 (The Lancet Respiratory Medicine, (S2213260020300795), (10.1016/S2213-2600(20)30079-5));Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

The Lancet Respiratory Medicine

Volumn 8, Issue 5, 2020, Pages 475-481

  Yang, Xiaobo ^a,b   Yu, Yuan ^a   Xu, Jiqian ^a   Shu, Huaqing ^a   Xia, Jia'an ^b   Liu, Hong ^a,b   Wu, Yongran ^a   Zhang, Lu ^c   Yu, Zhui ^d   Fang, Minghao ^a   Yu, Ting ^b   Wang, Yaxin ^a   Pan, Shangwen ^a   Zou, Xiaojing ^a   Yuan, Shiying ^a   Shang, You ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Jinyintan Hospital   (China)

^c HUBEI UNIVERSITY OF ARTS AND SCIENCE   (China)

^d RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; AGING; ARTICLE; ARTIFICIAL VENTILATION; CHINA; CHRONIC DISEASE; CLINICAL OUTCOME; COHORT ANALYSIS; COMORBIDITY; CORONAVIRUS DISEASE 2019; CRITICALLY ILL PATIENT; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FEVER; HEART INJURY; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LABORATORY TEST; LENGTH OF STAY; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; MORTALITY RISK; OBSERVATIONAL STUDY; PNEUMOTHORAX; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SURVIVAL TIME; SURVIVOR; SYMPTOMATOLOGY; BETACORONAVIRUS; CORONAVIRUS INFECTION; CRITICAL ILLNESS; ISOLATION AND PURIFICATION; MIDDLE AGED; MORTALITY; PANDEMIC; TREATMENT OUTCOME; VERY ELDERLY; VIROLOGY; VIRUS PNEUMONIA;

ADULT; AGED; AGED, 80 AND OVER; BETACORONAVIRUS; CHINA; CORONAVIRUS INFECTIONS; CRITICAL ILLNESS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PANDEMICS; PNEUMONIA, VIRAL; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 85079841872     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(20)30103-X     Document Type: Erratum

References (25)

1. Huang, C, Wang, Y, Li, X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 (2020), 497–506.
2. Chen, N, Zhou, M, Dong, X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395 (2020), 507–513.
3. Zhu, N, Zhang, D, Wang, W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 2020 published online Jan 24. DOI:10.1056/NEJMoa2001017.
4. Holshue, ML, DeBolt, C, Lindquist, S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med, 2020 published online Jan 31. DOI: 10.1056/NEJMoa2001191.
5. Wang, D, Hu, B, Hu, C, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 2020 published online Feb 7. DOI:10.1001/jama.2020.1585.
6. WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected, Jan 11, 2020. (Accessed 8 February 2020)
7. Dominguez-Cherit, G, Lapinsky, SE, Macias, AE, et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 302 (2009), 1880–1887.
8. Fowler, RA, Lapinsky, SE, Hallett, D, et al. Critically ill patients with severe acute respiratory syndrome. JAMA 290 (2003), 367–373.
9. Kumar, A, Zarychanski, R, Pinto, R, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 302 (2009), 1872–1879.
10. The International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC). https://isaric.tghn.org/. (Accessed 25 January 2020)
11. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-AKI-Guideline-English.pdf, March 2012. (Accessed 8 February 2020)
12. Parry, J, Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city. BMJ, 368, 2020, m351.
13. Lew, TW, Kwek, TK, Tai, D, et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA 290 (2003), 374–380.
14. Gomersall, CD, Joynt, GM, Lam, P, et al. Short-term outcome of critically ill patients with severe acute respiratory syndrome. Intensive Care Med 30 (2004), 381–387.
15. Arabi, YM, Arifi, AA, Balkhy, HH, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 160 (2014), 389–397.
16. de Wit, E, van Doremalen, N, Falzarano, D, Munster, VJ, SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 14 (2016), 523–534.
17. Bellani, G, Laffey, JG, Pham, T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315 (2016), 788–800.
18. USA TODAY. China built a hospital in 10 days to battle coronavirus. https://www.usatoday.com/story/news/world/2020/02/03/coronavirus-photos-show-wuhan-huoshenshan-hospital-built-10-days/4643377002/. (Accessed 8 February 2020)
19. Rothe, C, Schunk, M, Sothmann, P, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med, 2020 published online Jan 30. DOI: 10.1056/NEJMc2001468.
20. National Health Commission of the People's Republic of China. Asymptomatic cases complicate efforts. http://en.nhc.gov.cn/2020-02/01/c_76086.htm. (Accessed 8 February 2020)
21. Gu, J, Gong, E, Zhang, B, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med 202 (2005), 415–424.
22. Chu, H, Zhou, J, Wong, BH, et al. Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J Infect Dis 213 (2016), 904–914.
23. Liu, WJ, Zhao, M, Liu, K, et al. T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV. Antiviral Res 137 (2017), 82–92.
24. Liu, L, Yang, Y, Gao, Z, et al. Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study. J Thorac Dis 10 (2018), 5394–5404.
25. Russell, CD, Millar, JE, Baillie, JK, Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 395 (2020), 473–475.